Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer.

[1]  Arend Heerschap,et al.  Proton MR spectroscopy of prostatic tissue focused on the etection of spermine, a possible biomarker of malignant behavior in prostate cancer , 2000, Magnetic Resonance Materials in Physics, Biology and Medicine.

[2]  Guoying Liu,et al.  Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. , 2005, Cancer research.

[3]  Jason A Koutcher,et al.  Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. , 2005, Radiology.

[4]  K. Brandt,et al.  Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. , 2005, Radiology.

[5]  D. Yeung,et al.  Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T. , 2005, Clinical radiology.

[6]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[7]  R. Gonzalez,et al.  MRI in treatment of adult gliomas. , 2005, The Lancet. Oncology.

[8]  Wilbur L. Smith,et al.  Proton magnetic resonance spectroscopy of brain tumors correlated with pathology1 , 2005 .

[9]  Jiani Hu,et al.  Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. , 2005, Academic radiology.

[10]  D. Bluemke,et al.  Multiparametric and Multinuclear Magnetic Resonance Imaging of Human Breast Cancer: Current Applications , 2004, Technology in cancer research & treatment.

[11]  P. Carroll.  Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy , 2004 .

[12]  J. Kurhanewicz,et al.  Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.

[13]  D. Yee,et al.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. , 2004, Radiology.

[14]  Hedvig Hricak,et al.  Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  Wei Huang,et al.  Detection of breast malignancy: diagnostic MR protocol for improved specificity. , 2004, Radiology.

[16]  W. Chan,et al.  Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. , 2004, Journal of the Formosan Medical Association = Taiwan yi zhi.

[17]  I. Cox,et al.  1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration , 2004, NMR in biomedicine.

[18]  C. Balu-Maestro,et al.  Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI , 2002, Breast Cancer Research and Treatment.

[19]  P. Carroll,et al.  Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues , 2003, Magnetic resonance in medicine.

[20]  Mauricio Castillo,et al.  MR spectroscopy of brain tumors. , 2003, Magnetic resonance imaging clinics of North America.

[21]  Uwe Himmelreich,et al.  Pathologic characterization of human prostate tissue with proton MR spectroscopy. , 2003, Radiology.

[22]  P. Scardino,et al.  National Comprehensive Cancer Network guidelines for the management of prostate cancer. , 2003, Urology.

[23]  Daniel B Vigneron,et al.  In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI , 2002, Journal of magnetic resonance imaging : JMRI.

[24]  Wei-Tse Yang,et al.  Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. , 2002, Radiology.

[25]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[26]  R. Lenkinski,et al.  Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. , 2002, Journal of the National Cancer Institute.

[27]  J. Walecki,et al.  1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. , 2002, International journal of radiation oncology, biology, physics.

[28]  H. Lanfermann,et al.  Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions , 2002, Neuroradiology.

[29]  A. Rieber,et al.  Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy , 2002, European Radiology.

[30]  C E Mountford,et al.  Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine‐needle aspirates analysed using a statistical classification strategy , 2001, The British journal of surgery.

[31]  M D Schnall,et al.  MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. , 2001, Radiology.

[32]  N Sailasuta,et al.  Single‐voxel oversampled J‐resolved spectroscopy of in vivo human prostate tissue , 2001, Magnetic resonance in medicine.

[33]  R L Somorjai,et al.  Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.

[34]  W. Hall,et al.  Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. , 2001, AJNR. American journal of neuroradiology.

[35]  L Verhey,et al.  Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. , 2001, AJNR. American journal of neuroradiology.

[36]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[37]  S. Dwivedi,et al.  Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer , 2001, British Journal of Cancer.

[38]  J K Smith,et al.  Correlation of myo-inositol levels and grading of cerebral astrocytomas. , 2000, AJNR. American journal of neuroradiology.

[39]  W. Buchberger,et al.  Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. , 2000, Seminars in ultrasound, CT, and MR.

[40]  H. Shimizu,et al.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.

[41]  J. Frank,et al.  Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Arnold,et al.  Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. , 2000, Neurosurgery.

[43]  Bettuzzi Saverio,et al.  Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000 .

[44]  E. Adalsteinsson,et al.  In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. , 2000, AJNR. American journal of neuroradiology.

[45]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[46]  I. Gribbestad,et al.  Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[47]  S. Nelson,et al.  Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI , 1999, NMR in biomedicine.

[48]  W. Hall,et al.  Brain biopsy using high-field strength interventional magnetic resonance imaging. , 1999, Neurosurgery.

[49]  R. Lenkinski,et al.  Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.

[50]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  R. Kaplan.  Complexities, pitfalls, and strategies for evaluating brain tumor therapies. , 1998, Current opinion in oncology.

[52]  Mark A. Brown,et al.  Clinical MR Spectroscopy: First Principles , 1997 .

[53]  J Star-Lack,et al.  High spatial resolution and speed in MRSI , 1997, NMR in biomedicine.

[54]  Susan M. Chang,et al.  Age and the risk of anaplasia in magnetic resonance‐nonenhancing supratentorial cerebral tumors , 1997, Cancer.

[55]  W. Mackinnon,et al.  Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.

[56]  S. Piantadosi,et al.  Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.

[57]  W. Fair,et al.  Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. , 1997, The Journal of urology.

[58]  W. Reddick,et al.  Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. , 1996, International journal of radiation oncology, biology, physics.

[59]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[60]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[61]  B. Asselain,et al.  Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. , 1995, European journal of cancer.

[62]  D M Spielman,et al.  Three‐Dimensional Spectroscopic Imaging with Time‐Varying Gradients , 1995, Magnetic resonance in medicine.

[63]  P. Scardino,et al.  Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. , 1995, The Journal of urology.

[64]  Louis R Kavoussi,et al.  Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. , 1994, The Journal of urology.

[65]  J. Crook,et al.  Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. , 1993, International journal of radiation oncology, biology, physics.

[66]  M. Castillo,et al.  Radiologic-pathologic correlation: intracranial astrocytoma. , 1992, AJNR. American journal of neuroradiology.

[67]  M. Rathbone,et al.  Postoperative contrast enhancement in patients with brain tumor , 1985, Annals of neurology.

[68]  T. Ng,et al.  Application ofin vivo NMR spectroscopy to cancer , 1984, Magnetic resonance in medicine.